Correlation Between Century Therapeutics and Assembly Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Assembly Biosciences, you can compare the effects of market volatilities on Century Therapeutics and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Assembly Biosciences.

Diversification Opportunities for Century Therapeutics and Assembly Biosciences

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Century and Assembly is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Assembly Biosciences go up and down completely randomly.

Pair Corralation between Century Therapeutics and Assembly Biosciences

Given the investment horizon of 90 days Century Therapeutics is expected to generate 1.75 times more return on investment than Assembly Biosciences. However, Century Therapeutics is 1.75 times more volatile than Assembly Biosciences. It trades about 0.18 of its potential returns per unit of risk. Assembly Biosciences is currently generating about -0.03 per unit of risk. If you would invest  126.00  in Century Therapeutics on September 5, 2024 and sell it today you would earn a total of  29.00  from holding Century Therapeutics or generate 23.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  Assembly Biosciences

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Century Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Century Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Assembly Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Assembly Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong primary indicators, Assembly Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Century Therapeutics and Assembly Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and Assembly Biosciences

The main advantage of trading using opposite Century Therapeutics and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.
The idea behind Century Therapeutics and Assembly Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation